Pfizer: Arthritis trials

The registry lists 29 Arthritis studies with Pfizer as lead sponsor. 0 are open to participants now and 22 have results posted.

Phase 1 2Phase 2 5Phase 3 14Phase 4 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Efficacy Study Of Tofacitinib In Pediatric JIA PopulationCompletedNCT02592434Phase 3Results posted
• Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA)CompletedNCT01513902Phase 1Results posted
• Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic ArthritisCompletedNCT01500551Phase 2/3Results posted
• Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan)CompletedNCT01414257Results posted
• Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan)CompletedNCT01230177Results posted
• Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With OsteoarthritisTerminatedNCT01127893Phase 3Results posted
• Efficacy And Safety Study Of Tanezumab Subcutaneous Administration In Osteoarthritis - A Subcutaneous/Intravenous Bridging StudyTerminatedNCT01089725Phase 3Results posted
• Tanezumab In Osteoarthritis Of The Hip Or KneeTerminatedNCT00985621Phase 3Results posted
• A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis MedicationsCompletedNCT00856544Phase 3Results posted
• Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) TherapyCompletedNCT00848354Phase 4Results posted
• Tanezumab In Osteoarthritis Of The Knee (2)CompletedNCT00830063Phase 3Results posted
• Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or HipTerminatedNCT00809354Phase 3Results posted
• Tanezumab in Osteoarthritis Of The HipCompletedNCT00744471Phase 3Results posted
• Tanezumab in Osteoarthritis of the KneeCompletedNCT00733902Phase 3Results posted
• Study Evaluating the Safety of Enbrel (Etanercept)CompletedNCT00683384Results posted
• Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid ArthritisTerminatedNCT00634933Phase 2Results posted
• Study Evaluating the Efficacy and Safety of Etanercept and Methotrexate in Japanese Subjects With Rheumatoid ArthritisCompletedNCT00445770Phase 3Results posted
• Open-label Extension Study Of RN624CompletedNCT00399490Phase 2Results posted
• An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid ArthritisCompletedNCT00383188Phase 2Results posted
• Study Evaluating the Cost of the Treatments of the Refractory Psoriatic Arthritis to the Conventional TherapyCompletedNCT00303186Results posted
• Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by RheumatologistsCompletedNCT00293722Results posted
• Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by DermatologistsCompletedNCT00293709Results posted
• A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRACompletedNCT00652925Phase 3
• Study Evaluating AGG-523 in Subjects With Severe Osteoarthritis Requiring Total Knee ReplacementCompletedNCT00454298Phase 1
• Study Evaluating the Efficacy and Safety of Etanercept in Chinese Subjects With Rheumatoid ArthritisCompletedNCT00443950Phase 3
• A Study Comparing 4 Dose Regimens of PLA-695, Naproxen, and Placebo In Subjects With Osteoarthritis Of The KneeTerminatedNCT00396955Phase 2
• Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.CompletedNCT00393471Phase 3
• Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid ArthritisCompletedNCT00267852
• Study Evaluating Etanercept and Methotrexate in Plaque PsoriasisCompletedNCT00161655Phase 4